Compositions and methods for inhibiting kinases

A method of treating a mammal suffering from a bacterial infection or a viral infection, comprising administering to the mammal an effective amount of a compound of Formula (I) or a pharmaceutical composition thereof:

• wherein, independently for each occurrence,
• R1 is hydrogen, lower alkyl, —CH3, —CDH2, —CD2H, or —CD3;
• and
• Cy1 is heterocyclyl or substituted or unsubstituted 5-membered heteroaryl,
• wherein the bacterial infection is caused by Pseudomonas aeruginosa, Chlamydia trachomatis, Escherichia coli, Helicobacter pylori, Salmonella typhimurium, Shigella flexneri, or Mycobacterium tuberculosis;
• and
• the viral infection is caused by a Vaccinia virus, a variola virus, a polyoma virus, a Pox virus, a Herpes virus, cytomegalovirus, a human immunodeficiency virus, JC polyomavirus, BK polyomavirus, Simian virus 40, Monkeypox virus, Ebola virus, Marburg virus, Flavivirus, or West Nile virus.